Metabolism of inorganic arsenic and non-cancerous health hazards associated with chronic exposure in humans

Journal of Environmental Biology

Volumn 28, Issue 2 SUPPL., 2007, Pages 349-357

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Blackfoot disease; Health hazards; Human exposure; Inorganic arsenic; Neuropathy

Indexed keywords

ARSENIC; DRINKING WATER;

ARSENATE; ARSENIC; DRINKING WATER; HEALTH IMPACT; HEALTH RISK; METABOLISM; METHYLATION; POLLUTION EFFECT; POLLUTION EXPOSURE; TOXIC SUBSTANCE; TUMOR; WATER QUALITY;

ATHEROSCLEROSIS; BLACKFOOT DISEASE; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; HEALTH HAZARD; HUMAN; LONG TERM EXPOSURE; METHYLATION; NEUROPATHY; REVIEW; SKIN DEFECT; WATER CONTAMINATION;

EID: 34247586779     PISSN: 02548704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Ahmad, S.A., M.H. Sayed, S. Barua, M.H. Khan, M.H. Faruquee, A. Jalil, S.A. Hadi and H.K. Talukder: Arsenic in drinking water and pregnancy outcomes. Environ. Hlth. Perspect., 109(6), 629-631 (2001).
2. Ahmed, F.E.: Colon cancer: Prevalence, screening, gene expression and mutation and risk factors and assessment. J. Environ. Sci. Hlth. C, 21, 65-131 (2003).
3. Ahsan, H., M. Perrin, A. Rahman, F. Parvez, M. Stute, Y. Zheng, A.H. Milton, P. Brandt Rauf, A. van Geen and J.Graziano: Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J. Occup. Environ. Med., 42(12), 1195-1201 (2000).
4. Andreae, M.O.: Determination of arsenic species in natural waters. Annl. Chem., 49, 820-823 (1977).
5. Aposhian, H.V.: Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol., 37, 397-419 (1997).
6. Benigni, R. and A. Giuliani: Tumor geography of Italy and Europe: Patterns and correlations with socioeconomic variables. J. Environ. Sci. Hlth. C, 19, 325-351 (2001).
7. Berg, M., H.C. Tran, T.C. Nguyen, H.V. Pham, R. Schertenleib and W. Giger: Arsenic contamination of groundwater and drinking water in Vietnam: A human health threat. Environ. Sci. Technol., 35, 2621-2626 (2001).
8. Brown, K.G. and G.L. Ross: Arsenic, drinking water and health: A position paper of the American Council on Science and Health. Reg. Toxicol. Pharmacol., 36, 162-174 (2002).
9. Buchet, J.P., R. Lauwerys and H. Roels: Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium meta-arsenite by volunteers. Int. Arch. Occup. Environ. Hlth., 48, 111-118 (1981).
10. Calderon, J., M.E. Navarro, M.E. Jimenez Capdeville, M.A. Santos-Diaz, A. Golden, I. Rodriguez-Leyva, V. Borja-Aburto and F. Diaz-Barriga: Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ. Res., 85(2), 69-76 (2001).
11. Chang, T.C., M.C. Hong and C.J. Chen: Higher prevalence of goiter in endemic area of blackfoot disease of Taiwan. J. Formosan Med. Assoc., 90(10), 941-946 (1991).
12. Chen, C.J., H.Y. Chiou, W.I. Huang, S.Y. Chen, Y.M. Hsueh and C.H. Tseng: Systemic non-carcinogenic effects and developmental toxicity of inorganic arsenic. In: Arsenic: Exposure and health effects (Eds: C.O. Abernathy, R.L. Calderon and W.R. Chappell). Chapman and Hall Press, pp. 124-34 (1992).
13. Chen, C.J., L.I. Hsu, C.H. Tseng, Y.M. Hsueh and H.Y. Chiou: Emerging epidemics of arseniasis in Asia. In: Arsenic exposure and health effects (Eds: W.R. Chappell, C.O. Abernathy and R.L. Calderon). Elsevier Science Ltd., Oxford, U.K. pp. 113-121 (1992).
14. Chen, C.J., Y.M. Hsueh, M.S. Lai, M.P. Shyu, S.Y. Chen, M.M. Wu, T.L. Kuo and T.Y. Tai: Increased prevalence of hypertension and long-term arsenic exposure. Hypertension, 25, 53-60 (1995).
15. Chen, J.Z. and F.F. Kadlubar: Mitochondrial mutagenesis and oxidative stress in human prostate cancer. J. Environ. Sci. Hlth. C, 22, 1-12 (2004).
16. Chen, C.J. and L.J. Lin: Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic. In: Arsenic in the environment, Part II: Human health and ecosystem effects (Ed: J.O. Nriagu). New York, John Wiley and Sons Inc., pp. 109-131 (1994).
17. Chiou, H.Y., W.I. Huang, C.L. Su, S.F. Chang, Y.H. Hsu and C.J. Chen: Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke, 28, 1717-1723 (1997).
18. Col, M., C. Col, A. Soran, B.S. Sayli and S. Ozturk: Arsenic-related Bowen's disease, palmar keratosis and skin cancer. Environ. Hlth. Perspect., 107(8), 687-689 (1999).
19. Concha, G., G. Vogler, D. Lezcano, B. Nermell and M. Vahter: Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185-190 (1998).
20. Feldman, R.G.: Occupational and Environmental Neurotoxicology. Chapter 5, Arsenic. Lippincott-Raven Publishers, Philadelphia, New York, USA. pp. 69-91 (1999).
21. Fu, P.P., S.H. Cheng, L. Coop, Q. Xia, S.J. Culp, W.H. Tolleson, W.G. Warner and P.C. Howard: Photoreaction, phototoxicity, and photocarcinogenicity of retinoids. J. Environ. Sci. Hlth. C, 21, 165-197 (2003).
22. Gebel, T.W.: Arsenic methylation is a process of detoxification through accelerated excretion. Int. J. Hyg. Environ. Hlth., 205, 505-508 (2002).
23. Gerr, F., R. Letz, P.B. Ryan and R.C. Green: Neurological effects of environmental exposure to arsenic in dust and soil among humans. Neurotoxicology, 21, 475-487 (2000).
24. Haque, R., D.N. Mazumder, S. Samanta, N. Ghosh, D. Kalman, M.M. Smith, S. Mitra, A. Santra, S. Lahiri, S. Das, B.K. De and A.H. Smith: Arsenic in drinking water and skin lesions: Dose-response data from West Bengal, India. Epidemiology, 14(2), 174-182 (2003).
25. Healy, S.M., E.A. Casarez, F. Ayala-Fierro and H. Aposhian: Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol., 148, 65-70 (1998).
26. Hernandez-Zavala, A., L.M. Del Razo, C. Aguilar, G.C. Garcia-Vargas, V.H. Borja and M.E. Cebrian: Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico. Toxicol. Lett., 99(2), 79-84 (1998).
27. Hopenhayn-Rich, C., M.L. Biggs, D.A. Kalman, L.E. Moore and A.H. Smith: Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Hlth. Perspect., 104, 1200-1207 (1996a).
28. Hopenhayn-Rich, C., M.L. Biggs, A.H. Smith, D.A. Kalman and L.E. Moore: Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Hlth. Perspect., 104, 620-628 (1996b).
29. Hopenhayn-Rich, C., S.R. Browning, I. Hertz-Picciotto, C. Ferreccio, C. Peralta and H. Gibb: Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ. Hlth. Perspect., 108(7), 667-673 (2000).
30. Hopenhayn, C., C. Ferreccio, S.R. Browning, B. Huang, C. Peralta, H. Gibb and I. Hertz-Picciotto: Arsenic exposure from drinking water and birth weight. Epidemiology, 14(5), 593-602 (2003).
31. Hopenhayn-Rich, C., A.H. Smith and H.M. Goeden: Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res., 60, 161-177 (1993).
32. Hughes, M.F.: Arsenic toxicity and potential mechanisms of action. Toxicol. Lett., 133, 1-16 (2002).
33. Ihrig, M.M., S.L. Shalat and C. Baynes: A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiology, 9(3), 290-294 (1998).
34. Ishaque, A.B., P.B. Tchounwou, B.A. Wilson and T. Washington: Developmental arrest in Japanese medaka (Oryzias latipes) embryos exposed to sublethal concentrations of atrazine and arsenic trioxide. J. Environ. Biol., 25, 1-6 (2004).
35. Jenkins, R.B.: Inorganic arsenic and the nervous system. Brain, 89, 479-498 (1966).
36. Kitchin, K.T.: Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol., 172, 249-261 (2001).
37. Kreiss, K., M.M. Zack, P.J. Landrigan, R.G. Feldman, C.A. Niles, J. Chirico-Post, D.S. Sax, M.H. Boyd and D.H. Cox: Neurologic evaluation of a population exposed to arsenic in Alaskan well water. Arch. Environ. Hlth., 38, 116-121 (1983).
38. Kurttio, P., H. Komulainen, E. Hakala, H. Kahelin and J. Pekkanen: Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch. Environ. Contam. Toxicol., 34, 297-305 (1998).
39. Lai, M.S., Y.M. Hsueh, C.J. Chen, M.P. Shyu, S.Y. Chen and T.L. Kuo: Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol., 139, 484-492 (1994).
40. LeQuesne, P.M. and J.G. McLeod: Peripheral neuropathy following a single exposure to arsenic. Clinical course in four patients with electrophysiological and histological studies. J. Neurol. Sci., 32, 437-451 (1977).
41. Li, K. and S. Yu: Economic status, smoking, occupational exposure to rubber, and lung cancer: A case-cohort study. J. Environ. Sci. Hlth. C, 20, 21-28 (2002).
42. Lu, X., L.L. Arnold, S.M. Cohen, W.R. Cullen and X.C. Le: Speciation of dimethylarsinous acid and trimethylarsine oxide in urine from rats fed with dimethylarsinic acid and dimercaptopropane sulfonate. Annl. Chem., 75, 6463-6468 (2003).
43. Ma, M. and X.C. Le: Effect of arsenosugar ingestion on urinary arsenic speciation. Clin. Chem., 44, 539-550 (1998).
44. Marafante, E., M. Vahter, H. Norin, J. Envall, M. Sandstrom, A. Christakopoulos and R. Ryhage: Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol., 7, 111-117 (1987).
45. Mazumder, D.N., J. Das Gupta, A. Santra, A. Pal, A. Ghose and S. Sarkar: Chronic arsenic toxicity in west Bengal - The worst calamity in the world. J. Indian Med. Assoc., 96(1), 4-7 (1998).
46. Mazumder, D.N., R. Haque, N. Ghosh, B.K. De, A. Santra, D. Chakraborti and A.H. Smith: Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol., 29(6), 1047-1052 (2000).
47. Milton, A.H. and M. Rahman: Respiratory effects and arsenic contaminated well water in Bangladesh. Int. J. Environ. Hlth. Res., 12(2), 175-179 (2002).
48. Murphy, M.J., L.W. Lyon and J.W. Taylor: Subacute arsenic neuropathy: clinical and electrophysiological observations. J. Neurol. Neurosurg Psychiatry, 44, 896-900 (1981).
49. Naranjo-Pulido, A., H. Romero-Schmidt, L. Mendez-Rodriguez, B. Acosta-Vargas and A. Ortega-Rubio: Soil arsenic contamination in the Cape Region, B.C.S., Mexico. J. Environ. Biol., 23, 347-352 (2002).
50. Oh, J.S.: Electrophysiological profile in arsenic neuropathy. J. Neurol. Neurosurg Psychiatry, 54, 1103-1105 (1991).
51. Rahman, M. and O. Axelson: Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup. Environ. Med., 52, 773-774 (1995).
52. Rahman, M.M., U.K. Chowdhury, S.C. Mukherjee, B.K. Mondal, K. Paul, D. Lodh, B.K. Biswas, C.R. Chanda, G.K. Basu, K.C. Saha, S. Roy, R. Das, S.K. Palit, Q. Quamruzzaman, D. Chakraborti: Chronic arsenic toxicity in Bangladesh and West Bengal, India-a review and commentary. J. Toxicol. Clin. Toxicol., 39, 683-700 (2001).
53. Rahman, M., M. Tondel, S.A. Ahmad and O. Axelson: Diabetes mellitus associated with arsenic exposure in Bangladesh. Am. J. Epidemiol., 148, 198-203 (1998).
54. Rahman, M., M. Tondel, S.A. Ahmad, I.A. Chowdhury, M.H. Faruquee and O. Axelson: Hypertension and arsenic exposure in Bangladesh. Hypertension, 33(1), 74-78 (1999a).
55. Rahman, M., M. Tondel, I.A. Chowdhury and O. Axelson: Relations between exposure to arsenic, skin lesions and glucosuria. Occup. Environ. Med., 56, 277-281 (1999b).
56. Rahman, M., G. Wingren and O. Axelson: Diabetes mellitus among Swedish art glassworkers - An effect of arsenic exposure? Scand. J. Work Environ. Hlth., 22, 146-149 (1996).
57. Rosen, B.P.: Biochemistry of arsenic detoxification. FEBS Lett., 529, 86-92 (2002).
58. Santra, A., J. Das Gupta, B.K. De, B. Roy and D.N. Guha Mazumder: Hepatic manifestations in chronic arsenic toxicity. Indian J. Gastroenterol., 18(4), 152-155 (1999).
59. Schoen, A., B. Beck, R. Sharma and E. Dube: Arsenic toxicity at low doses: Epidemiological and mode of action considerations. Toxicol. Appl. Pharmacol., 198, 253-267 (2004).
60. Shraim, A., N.C. Sekaran, C.D. Anuradha and S. Hirano: Speciation of arsenic in tube-well water samples collected from West Bengal, India, by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Appl. Organomet. Chem., 16, 1-8 (2002).
61. Siripitayakunkit, U., P. Visudhiphan, M. Pradipasen, T. Vorapongsathron: Assocication between chronic arsenic exposure and children's intelligence in Thailand. In: Arsenic Exposure and Health Effects: Proceedings of the Third International Conference on Arsenic Exposure and Health Effects (Eds: W.R. Chappell, C.O. Abernathy and R.L. Calderon). Elsevier, New York. pp. 141-150 (1999).
62. Smith, A.H. and M.M.H. Smith: Arsenic drinking water regulations in developing countries with extensive exposure. Toxicology, 198, 39-44 (2004).
63. Styblo, M., Z. Drobna, I. Jaspers, S. Lin and D.J. Thomas: The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Hlth. Perspect., 110(Suppl 5), 767-771 (2002).
64. Talaska, G.: Aromatic amines and human urinary bladder cancer: Exposure sources and epidemiology. J. Environ. Sci. Hlth. C, 21, 29-43 (2003).
65. Thomas, D.J., M. Styblo and S. Lin: The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol., 176, 127-144 (2001).
66. Thomas, D.J., S.B. Waters and M. Styblo: Elucidating the pathway for arsenic methylation. Toxicol. Appl. Pharmacol., 198, 319-326 (2004).
67. Thompson, D.J.: A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact., 88, 89-14 (1993).
68. Tokunaga, H., T. Roychowdhury, N. Chandraskaran, T. Uchino and M. Ando: Urinary arsenic species in an arsenic-affected area of West Bengal, India. Appl. Organomet. Chem., 16, 406-414 (2002).
69. Tondel, M., M. Rahman, A. Magnuson, I.A. Chowdhury, M.H. Faruquee and S.A. Ahmad: The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Hlth. Perspect., 107(9), 727-729 (1999).
70. Triebig, G. and J. Buttner: Neurotoxic occupational substances: I. Metals and their compounds. A literature review of the years 1970 to 1982 [in German]. Zentralbl. Bakteriol. Mikrobiol. Hyg. [B], 177, 11-36 (1983).
71. Tsai, S.Y., Chou H.Y., H.W. The, C.M. Chen and C.J. Chen: The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology, 24(4-5), 747-753 (2003).
72. Tsai, S.M., T.N. Wang and Y.C. Ko: Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Hlth., 54(3), 186-193 (1999).
73. Tseng, C.H.: Chronic arsenic intoxication in Asia: Current perspectives. J. Intern. Med. Taiwan, 10, 224-229 (1999).
74. Tseng, C.H.: An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology, 53, 529-537 (2002).
75. Tseng, C.H.: Abnormal current perception thresholds measured by Neurometer among residents in blackfoot disease hyperendemic villages in Taiwan. Toxicol. Lett., 146, 27-36 (2003).
76. Tseng, C.H.: The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol. Appl. Pharmacol., 197, 67-83 (2004).
77. Tseng, C.H.: Blackfoot disease and arsenic: A never-ending story. Environ Carcinog Ecotoxicol Rev., J. Environ. Sci. Hlth. C, 23, 55-74 (2005).
78. Tseng, C.H., C.J. Chen, B.J. Lin and T.Y. Tai: Abnormal response of ankle pressure after exercise in seemingly normal subjects living in blackfoot disease-Hyperendemic villages in Taiwan. Vasc Surg., 28, 607-617 (1994).
79. Tseng, C.H., C.K. Chong, C.J. Chen and T.Y. Tai: Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis, 120, 125-133 (1996).
80. Tseng, C.H., C.K. Chong, C.J. Chen and T.Y. Tai: Lipid profile and peripheral vascular disease in arseniasis-hyperendemic villages in Taiwan. Angiology, 48, 321-335 (1997).
81. Tseng, C.H., C.K. Chong, L.T. Heng, C.P. Tseng and T.Y. Tai: The incidence of diabetes mellitus in Taiwan. Diabetes Res. Clin. Pract., 50(Suppl 2), S61-S64 (2000a).
82. Tseng, C.H., C.K. Chong, C.P. Tseng, Y.H. Hsueh, H.Y. Chiou, C.C. Tseng and C.J. Chen: Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett., 137, 15-21 (2003).
83. Tseng, C.H., Y.K. Huang, Y.L. Huang, C.J. Chung, M.H. Yang, C.J. Chen and Y.M. Hsueh: Arsenic exposure, urinary arsenic speciation and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol., 206, 299-308 (2005).
84. Tseng, C.H., T.Y. Tai, C.K. Chong, C.P. Tseng, M.S. Lai, B.J. Lin, H.Y. Chiou, Y.M. Hsueh, K.H. Hsu and C.J. Chen: Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ. Hlth. Perspect., 108, 847-851 (2000b).
85. Tseng, C.H., T.Y. Tai, B.J. Lin and C.J. Chen: Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot disease-hyperendemic villages in Taiwan. Int. J. Microcirc., 15, 21-27 (1995).
86. Tseng, C.H., C.P. Tseng, H.Y. Chiou, Y.M. Hsueh, C.K. Chong and C.J. Chen: Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol. Lett., 133, 69-76 (2002).
87. Tseng, W.P.: Blackfoot disease in Taiwan: A 30-year follow-up study. Angiology, 40, 547-558 (1989).
88. Tseng, W.P., H.M. Chu, S.W. How, J.M. Fong, C.S. Lin and S. Yeh: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst., 40, 453-463 (1968).
89. Vahter, M.: Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog., 82(Pt 1), 69-88 (1999).
90. Vahter, M.: Mechanisms of arsenic biotransformation. Toxicology, 181-182, 211-217 (2002).
91. Vardhanan, Y.S. and T. Radhakrishnan: Acute toxicity evaluation of copper, arsenic and HCH to paddy field crab, Paratelphusa hydrodromus (Herb.). J. Environ. Biol., 23, 387-392 (2002).
92. Wen Cheng, Y. and H. Lee: Environmental exposure and lung cancer among nonsmokers: An example of Taiwanese female lung cancer. J. Environ. Sci. Hlth. C, 21, 1-28 (2003).
93. Windebank, A.J.: Specific inhibition of myelination by lead in vitro; comparison with arsenic, thallium and mercury. Exp. Neurol., 94, 203-212 (1986).
94. Yamamura, S.: Arsenic and fluoride in drinking water; WHO'S recent endeavours. WHO, Geneva, Switzerland for the Pan-Asia-Pacific Conference on Fluoride and Arsenic Research, Shenyang, China. pp. 16-20 (1999).